InsidersTradesSigma
CStone Pharmaceuticals - B: insider trades · Hong Kong · HKEX
HKEX:cstone-pharmaceuticals-bHK·HKEXMcap 12.5Bn€Healthcare
Discover the full directors' dealings record of CStone Pharmaceuticals - B, a listed issuer based in Hong Kong. Shares are listed on HK HK, under the supervision of HKEX. Operating in the Healthcare sector, CStone Pharmaceuticals - B has recorded 1 reports. Market capitalisation: €12.5bn. The latest transaction was disclosed on 12 May 2026 — Other. Among the most active insiders: Li Wei. All data is accessible without an account.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
7.85 €
Analyst consensus
4 analysts9.60 €Target 14.36 €(+83%)20.32 €
Income statement
Revenue269.6 M€
Gross profit51.2 M€19% margin
Net income−437.0 M€-162.1% margin
Valuation
PER (forward)-49.8x
P/Book16.3x
Beta0.25
Balance sheet & cash
Market cap12.55 Bn€
Total debt348.5 M€
Free Cash Flow−327.7 M€
Debt / Equity57%
Profitability & ownership
ROE-89.1%
ROA-18.9%
% insiders22.1%
% institutions15.5%
Last declaration on 12 May 2026